Series C funding round for Glycomine raising $120M in April 2025
Series C funding round for Glycomine raising $120M in April 2025
| Investor | Firm Type | Partner |
|---|
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$200M
Top Valuation
-
Glycomine raised $120M in a Series C round.
The round was announced on 04/01/25.
The round was led by Advent Life Sciences, CTI Life Sciences Fund.